NASDAQ:BSGM - BioSig Technologies Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$5.12 +0.59 (+13.02 %)
(As of 02/15/2019 04:00 PM ET)
Previous Close$5.12
Today's Range$4.59 - $5.49
52-Week Range$3.21 - $7.88
Volume126,324 shs
Average Volume31,834 shs
Market Capitalization$85.32 million
P/E RatioN/A
Dividend YieldN/A
BioSig Technologies, Inc., a development stage medical device company, engages in developing a proprietary biomedical signal processing technology platform to extract information from physiologic signals. Its product is PURE (Precise Uninterrupted Real-time evaluation of Electrograms) EP System, a surface electrocardiogram and intracardiac multichannel recording and analysis system that acquires, processes, and displays electrocardiogram and electrograms required during electrophysiology studies and catheter ablation procedures. It is also developing a library of software tools that are designed to be configured to fit the needs of electrophysiologists in various settings and for arrhythmia treatments. The company was founded in 2009 and is headquartered in Los Angeles, California.

Receive BSGM News and Ratings via Email

Sign-up to receive the latest news and ratings for BSGM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Electromedical equipment
Current SymbolNASDAQ:BSGM



Sales & Book Value

Annual SalesN/A
Book Value($0.28) per share


Net Income$-12,690,000.00


Market Cap$85.32 million
OptionableNot Optionable

BioSig Technologies (NASDAQ:BSGM) Frequently Asked Questions

What is BioSig Technologies' stock symbol?

BioSig Technologies trades on the NASDAQ under the ticker symbol "BSGM."

How were BioSig Technologies' earnings last quarter?

BioSig Technologies Inc (NASDAQ:BSGM) posted its earnings results on Friday, August, 12th. The company reported ($0.32) EPS for the quarter. View BioSig Technologies' Earnings History.

What price target have analysts set for BSGM?

1 brokers have issued 12 month price objectives for BioSig Technologies' stock. Their predictions range from $14.00 to $14.00. On average, they anticipate BioSig Technologies' stock price to reach $14.00 in the next twelve months. This suggests a possible upside of 173.4% from the stock's current price. View Analyst Price Targets for BioSig Technologies.

What is the consensus analysts' recommendation for BioSig Technologies?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BioSig Technologies in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for BioSig Technologies.

Has BioSig Technologies been receiving favorable news coverage?

Headlines about BSGM stock have been trending neutral on Saturday, according to InfoTrie Sentiment. The research group identifies positive and negative press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. BioSig Technologies earned a daily sentiment score of 0.2 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 9.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the company's share price in the near future.

Who are some of BioSig Technologies' key competitors?

Who are BioSig Technologies' key executives?

BioSig Technologies' management team includes the folowing people:
  • Mr. Kenneth L. Londoner M.B.A., MBA, Founder, CEO & Exec. Chairman (Age 51)
  • Mr. Steven Chaussy, Chief Financial Officer (Age 65)
  • Ms. Lora Mikolaitis, VP of Admin. (Age 46)
  • Mrs. Tiffini Wittwer, Chief Regulatory & Compliance Officer
  • Ms. Natasha Drapeau, Exec. VP

Who are BioSig Technologies' major shareholders?

BioSig Technologies' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Millennium Management LLC (0.94%) and Virtu Financial LLC (0.07%). Company insiders that own BioSig Technologies stock include Andrew Lawrence Filler, Donald E Foley, Joseph Rafferty, Kenneth L Londoner, Lora Mikolaitis, Patrick Joseph Gallagher and Steve Chaussy. View Institutional Ownership Trends for BioSig Technologies.

Which institutional investors are buying BioSig Technologies stock?

BSGM stock was purchased by a variety of institutional investors in the last quarter, including Millennium Management LLC and Virtu Financial LLC. Company insiders that have bought BioSig Technologies stock in the last two years include Andrew Lawrence Filler, Donald E Foley, Joseph Rafferty, Kenneth L Londoner, Patrick Joseph Gallagher and Steve Chaussy. View Insider Buying and Selling for BioSig Technologies.

How do I buy shares of BioSig Technologies?

Shares of BSGM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is BioSig Technologies' stock price today?

One share of BSGM stock can currently be purchased for approximately $5.12.

How big of a company is BioSig Technologies?

BioSig Technologies has a market capitalization of $85.32 million. BioSig Technologies employs 14 workers across the globe.

What is BioSig Technologies' official website?

The official website for BioSig Technologies is

How can I contact BioSig Technologies?

BioSig Technologies' mailing address is 12424 WILSHIRE BOULEVARD SUITE 745, LOS ANGELES CA, 90025. The company can be reached via phone at 512-329-2643 or via email at [email protected]

MarketBeat Community Rating for BioSig Technologies (NASDAQ BSGM)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  6 (Vote Outperform)
Underperform Votes:  4 (Vote Underperform)
Total Votes:  10
MarketBeat's community ratings are surveys of what our community members think about BioSig Technologies and other stocks. Vote "Outperform" if you believe BSGM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BSGM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/16/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel